Lilly employees charged with IP theft

Share this article:

Three former Eli Lilly employees have been accused of selling the drug maker's secrets to a Chinese drug company. The Indiana Business Journal reports that the unsealed federal indictment charges two scientists with seven counts of theft and conspiracy to commit theft, and a third is noted as being a participant. The scientists, Guoqing Cao and Shuyu Li, were arrested on Oct. 1.

IBJ reports Lilly's head of global development testified that Cao and Li shared trade secrets that would allow the competing drug maker to create drugs for cardiovascular diseases, diabetes and cancer.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.